This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...